In a recent clinical trial in Cleveland, researchers discovered that a medicine prescribed as injectable non-insulin drug can boost visceral fat reduction. The medical community welcomed the discovery of a team of researchers from UH Harrington Heart & Vascular Institute, as their findings will be of great help to overweight or obese people looking to..